Intervention Protocol

NSAIDs, analgesics and opioids agents for fibromyalgia syndrome

  1. Luis Ernesto González2,
  2. María Betina Nishishinya3,
  3. Loreto Carmona4,
  4. Paul Michael J Peloso5,
  5. Brian Walitt6,
  6. Godwin Darko6,
  7. Gerard Urrútia1,*

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 18 APR 2007

DOI: 10.1002/14651858.CD006554


How to Cite

González LE, Nishishinya MB, Carmona L, Peloso PMJ, Walitt B, Darko G, Urrútia G. NSAIDs, analgesics and opioids agents for fibromyalgia syndrome (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006554. DOI: 10.1002/14651858.CD006554.

Author Information

  1. 1

    Hospital de la Santa Creu i Sant Pau., Centro Cochrane Iberoamericano. CIBER Epidemiología y Salud Pública (CIBERESP) Spain, Barcelona, Spain

  2. 2

    Universidad Tecnológica Equinoccial, Quito, Ecuador

  3. 3

    Hospital de la Santa Creu i Sant Pau, Centro Cochrane Iberoamericano, Barcelona, Spain

  4. 4

    Rheumatology Organization, Madrid, Spain

  5. 5

    Basking Ridge, NJ, USA

  6. 6

    Washington Hospital Center, Department of Medicine, Washington, DC, USA

*Gerard Urrútia, Centro Cochrane Iberoamericano. CIBER Epidemiología y Salud Pública (CIBERESP) Spain, Hospital de la Santa Creu i Sant Pau., c/ Sant Antoni Maria Claret 171, Barcelona, 08041, Spain. gurrutia@santpau.cat.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of non-steroidal anti-inflammatory drugs, analgesics and opioids agents (including opiates) in the treatment of fibromyalgia syndrome using the key domains that derived from consensus among experts in the area (Mease 2005; OMERACT 7).